🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study was to evaluate the efficacy, safety and tolerability...
Status
Not Yet Recruiting
Location
Breast Cancer Center Shandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences
Start Date
2025-08-01
Trial ID
NCT07093931
Treatments Being Tested
This is a single cohort observational safety study. All patients will be tr...
Status
Completed
Location
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie
Start Date
2007-08-30
Trial ID
NCT01152606
Treatments Being Tested
This study is designed to evaluate the safety and efficacy of JSKN003 combi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-06-15
Trial ID
NCT06998771
Treatments Being Tested
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
Prospective, multi-center, randomized, open label comparative Phase III stu...
Status
Recruiting
Location
University Clinic Ulm
Start Date
2025-04-22
Trial ID
NCT06643585
Treatments Being Tested
In this study, investigators utilize a radiopathomics integrated Artificial...
Status
Unknown
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06396143
The purpose of this research study is to find out what effects (good and ba...
Status
Completed
Location
Birmingham Hematology and Oncology
Start Date
2007-06
Trial ID
NCT00493649
This study was originally designed as a Phase III randomized, double blind,...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-12-13
Trial ID
NCT00272987
Treatments Being Tested
This retrospective cohort study aims to improve our understanding of the cu...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-06
Trial ID
NCT01064349
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Completed
Location
Kantonspital Aarau
Start Date
2005-05
Trial ID
NCT00238290
Treatments Being Tested